Devyser Diagnostics AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	242.7	216.9	169.3	126.6	93.48	65.69
Revenue Growth (YoY)	22.51%	28.12%	33.73%	35.43%	42.31%	2.15%
Cost of Revenue	43.8	44.2	24.5	23.2	21.57	18.67
Gross Profit	198.9	172.7	144.8	103.4	71.91	47.02
Selling, General & Admin	186.3	193.1	163.5	132.1	75.65	41.9
Research & Development	24.8	43.1	37.8	26.3	18.07	16.68
Other Operating Expenses	-0.9	-0.9	-0.3	-0.2	-0.12	-2.38
Operating Expenses	210.2	235.3	201	158.2	93.6	56.21
Operating Income	-11.3	-62.6	-56.2	-54.8	-21.69	-9.19
Interest Expense	-12.3	-3.5	-0.8	-0.5	-0.94	-0.93
Interest & Investment Income	0.8	4.2	5	0.3	0.01	0
Earnings From Equity Investments	-	-	-	-	0.37	-1.04
Currency Exchange Gain (Loss)	4.1	4.8	-2.3	1.2	0.06	-0.74
Other Non Operating Income (Expenses)	-0.1	-0.1	-	-	0.22	0
EBT Excluding Unusual Items	-18.8	-57.2	-54.3	-53.8	-21.97	-11.9
Gain (Loss) on Sale of Investments	-	-	-	1.6	-	-
Gain (Loss) on Sale of Assets	-0.4	-0.4	-0.4	0.1	0.07	-
Asset Writedown	-	-	0.3	-0.7	-0	-
Pretax Income	-19.2	-57.6	-54.4	-52.8	-21.91	-11.9
Income Tax Expense	6	3.9	-0.8	-6.8	-1.18	-0.99
Net Income	-25.2	-61.5	-53.6	-46	-20.73	-10.91
Net Income to Common	-25.2	-61.5	-53.6	-46	-20.73	-10.91
Shares Outstanding (Basic)	17	16	16	16	11	9
Shares Outstanding (Diluted)	17	16	16	16	11	9
Shares Change (YoY)	1.35%	1.34%	1.63%	41.78%	28.98%	-4.34%
EPS (Basic)	-1.52	-3.75	-3.31	-2.89	-1.85	-1.25
EPS (Diluted)	-1.53	-3.75	-3.31	-2.89	-1.85	-1.25
Free Cash Flow	-8.7	-72.6	-81.2	-48.4	-18.68	0.55
Free Cash Flow Per Share	-0.53	-4.43	-5.02	-3.04	-1.66	0.06
Gross Margin	81.95%	79.62%	85.53%	81.67%	76.93%	71.58%
Operating Margin	-4.66%	-28.86%	-33.20%	-43.29%	-23.20%	-13.99%
Profit Margin	-10.38%	-28.35%	-31.66%	-36.34%	-22.17%	-16.61%
Free Cash Flow Margin	-3.58%	-33.47%	-47.96%	-38.23%	-19.98%	0.84%
EBITDA	-5.6	-56.1	-52.5	-52.6	-20.99	-8.63
EBITDA Margin	-2.31%	-25.86%	-31.01%	-41.55%	-22.46%	-13.13%
D&A For EBITDA	5.7	6.5	3.7	2.2	0.69	0.57
EBIT	-11.3	-62.6	-56.2	-54.8	-21.69	-9.19
EBIT Margin	-4.66%	-28.86%	-33.20%	-43.29%	-23.20%	-13.99%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.